Prostatype Genomics AB
Genomic classifier test guides prostate cancer treatment decisions for patients.
Overview
- 5–9
- Employees
- 200–299K SEK
- Revenue
- 2007
- Founded
Description
Prostatype Genomics is a specialized biotechnology company focused on improving outcomes for men diagnosed with localized prostate cancer. They provide the Prostatype® Genomic Classifier (PGC™), a next-generation prognostic test developed from extensive research at the Karolinska Institute. This non...